Workup and Management of Hematuria in a 56-Year-Old Male
A 56-year-old male with hematuria requires risk stratification followed by cystoscopy and upper tract imaging with CT urography (CTU) if he has any risk factors for urothelial malignancy, which at his age and gender, he almost certainly does.
Initial Assessment and Risk Stratification
First, determine whether this is gross hematuria (visible blood) or microhematuria (≥3 RBC/HPF on microscopic urinalysis). This distinction is critical:
- Gross hematuria carries a 30-40% malignancy risk and mandates full urologic workup 1
- Microhematuria carries a 2.6-4% malignancy risk but still requires evaluation in this patient 1
Key Risk Factors to Assess
Your patient has at least two high-risk factors by default (male gender and age >50 years). Additionally, evaluate for 2, 1:
- Smoking history (>10 pack-years increases risk significantly)
- Occupational chemical exposure
- History of pelvic irradiation
- Chronic UTIs or indwelling catheters
- Analgesic abuse
- Prior urologic disease
- Irritative voiding symptoms
According to 2020 AUA guidelines, men aged 40-59 years are automatically intermediate-risk, and those ≥60 years are high-risk 2. Your 56-year-old male patient falls into the intermediate-risk category at minimum.
Exclude Benign Transient Causes
Before proceeding with extensive workup, rule out:
- Urinary tract infection: Obtain urine culture. If positive, treat with antibiotics and repeat urinalysis after treatment. Persistent hematuria after infection clearance requires full evaluation 1
- Recent vigorous exercise
- Recent urologic procedures
- Trauma
Critical caveat: Anticoagulation does NOT explain hematuria and should not prevent full evaluation 1.
Required Workup for This Patient
1. Laboratory Studies
- Urinalysis with microscopy (confirm ≥3 RBC/HPF)
- Urine culture
- Serum creatinine
- Consider PSA given age and gender
2. Upper Tract Imaging: CT Urography
CT urography is the gold standard imaging modality for evaluating the upper urinary tract in patients with hematuria and risk factors 1.
CTU protocol includes:
- Unenhanced phase (detects stones)
- Nephrographic phase (evaluates renal parenchyma)
- Excretory phase at ≥5 minutes post-contrast (evaluates collecting system and ureters)
- Thin-slice acquisition with multiplanar reconstructions
Alternative: MR urography if contrast allergy or radiation concerns exist, though CT remains preferred 1.
The ACR guidelines note that ultrasound alone is insufficient for intermediate/high-risk patients, as it misses urothelial lesions and has poor sensitivity for renal masses 1.
3. Lower Tract Evaluation: Cystoscopy
Cystoscopy is mandatory for evaluating the bladder and urethra, as imaging cannot adequately assess for:
- Bladder tumors (especially flat lesions like carcinoma in situ)
- Urethral pathology
- Benign prostatic hyperplasia
This should be performed by urology 2, 1.
When to Consider Nephrology Referral
If urinalysis shows any of the following, concurrent nephrology evaluation is warranted (but does not replace urologic workup) 1:
- Dysmorphic RBCs
- RBC casts
- Proteinuria (especially >500 mg/day)
- Elevated creatinine
- Hypertension in setting of hematuria
These suggest glomerular disease rather than urologic pathology.
Common Pitfalls to Avoid
Do not attribute hematuria to anticoagulation alone - these patients still require full evaluation 1
Do not stop at ultrasound - while CUA guidelines suggest ultrasound as first-line 3, ACR and AUA guidelines emphasize that ultrasound misses significant pathology in intermediate/high-risk patients 1
Do not skip cystoscopy - imaging alone is insufficient for lower tract evaluation 2, 1
Do not delay evaluation - even transient hematuria in older males warrants investigation, as malignancy can present intermittently 4, 5
Urine cytology is no longer routinely recommended unless specific high-risk features are present 6
Risk-Stratified Approach Summary
For your 56-year-old male (intermediate-risk minimum):
- Confirm hematuria on repeat urinalysis if microhematuria
- Rule out infection
- CT urography for upper tract
- Cystoscopy for lower tract
- Consider nephrology if glomerular features present
If gross hematuria: Proceed directly to full workup without delay given 30-40% malignancy risk 1.
Follow-up After Negative Evaluation
If initial workup is negative, the 2020 AUA guidelines recommend 2:
- Repeat urinalysis at intervals
- If hematuria persists, shared decision-making regarding repeat evaluation
- Immediate re-evaluation if: development of gross hematuria, significant increase in degree of microhematuria, or new urologic symptoms
The diagnostic yield of repeated evaluations after negative workup is very low, but changes in clinical status warrant reassessment 2.